Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2010-05-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
Placebo with berries (blackberries + strawberries)
placebo
Placebo with berries (blackberries + strawberries)
omeprazole
Prilosec (omeprazole) 20.6 mg tablet with berries (blackberries + strawberries)
omeprazole
omeprazole 20.6 mg tablet with berries (blackberries + strawberries)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
omeprazole
omeprazole 20.6 mg tablet with berries (blackberries + strawberries)
placebo
Placebo with berries (blackberries + strawberries)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 22 to 59 years
Exclusion Criteria
* Has implanted or portable electro-mechanical medical device such as a cardiac pacemaker or infusion pump
* Suspected strictures, fistulas or physiological GI obstruction
* Allergy to omeprazole
* Current use of clopidogrel (Plavix) or use within the past 3 months
* Use of warfarin, prescription antifungals/anti-yeast drugs, diazepam, and digoxin
* Chronic daily use of nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen, etc.)
* History of bariatric or other gastric surgery
* Frequent use of antacids
* Use of proton pump inhibitors in past 3 months
* History of acid reflux
* History of gastrointestinal disorders or gastrointestinal surgery
* History of bezoars (packed collection of partially digested or undigested material that is unable to exit the stomach)
* Crohn's disease, diverticulitis or inflammatory bowel disease
* Inability to swallow large pills
* Dysphagia (Trouble or pain with swallowing food or pills)
* Allergy to strawberries or blackberries
* Pregnant women
* Lactating women
* Pregnancy in last 12 months
* History of kidney disease
* History of liver disease
* History of metabolic disorder
* History of some cancers
* Tobacco use in past 6 months
* Use of oral or IV antibiotics in past month
* Use of herbal supplement in past month
22 Years
59 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USDA Beltsville Human Nutrition Research Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Janet Novotny
Research Physiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beverly Clevidence, Ph. D.
Role: PRINCIPAL_INVESTIGATOR
USDA Beltsville Human Nutrition Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USDA's Beltsville Human Nutrition Research Center
Beltsville, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-069
Identifier Type: -
Identifier Source: org_study_id